| DHEAS | 30 days pg/mL | % | Dif 2/3 pg/mL | % | 60 days pg/mL | % | ||
| Baseline | Treatment | Post-Treatment |
|
|
|
|
|
|
| 4.4 | 5.5 | 7.2 | −1.1 | 24.9% | −1.7 | 30.9% | −2.8 | 63.6% |
| 12.2 | 13.0 | 9.5 | −0.8 | 6.5% | 3.5 | −26.9% | 2.7 | −22.1% |
| 1.3 | 1.4 | 0.7 | −0.1 | 7.7% | 0.7 | −50.0% | 0.6 | −46.2% |
| 5.2 | 2.8 | 3.5 | 2.4 | −46.2% | −0.7 | 25.0% | 1.7 | −32.7% |
| 6.7 | 7.5 | 8.8 | −0.8 | 11.9% | −1.3 | 17.3% | −2.1 | 31.3% |
| 7.6 | 8.8 | 5.6 | −1.2 | 15.8% | 3.2 | −36.4% | 2.0 | −26.3% |
| 9.5 | 20.7 | 12.5 | −11.2 | 117.9% | 8.2 | −39.6% | −3.0 | 31.6% |
| 13.2 | 16.2 | 11.1 | −3.0 | 22.7% | 5.1 | −31.5% | 2.1 | −15.9% |
| Mean Increase: | 2.6 pg/mL | 29.6% |
|
|
|
| ||